Salivary gland carcinoma

You have access
Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma
KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA and TAKASHI NAKAGAWA

Anticancer Research February 2022, 42 (2) 981-989; DOI: https://doi.org/10.21873/anticanres.15558
You have access
Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands
DIRK RADES, AMIRA BAJROVIC and TOBIAS BARTSCHT

Anticancer Research December 2017, 37 (12) 7011-7015;
You have access
Adjuvant Therapy for Salivary Gland Carcinomas
MUTLAY SAYAN, PRASHANT VEMPATI, BRETT MILES, MARITA TENG, ERIC GENDEN, ELIZABETH G. DEMICCO, KRZYSZTOF MISIUKIEWICZ, MARSHALL POSNER, VISHAL GUPTA and RICHARD L. BAKST

Anticancer Research August 2016, 36 (8) 4165-4170;

Main menu